In a preclinical model of DKD, Nrf2 expression is found to be downregulated in association with enhanced ROS production via upregulation of Keap1 leading to depletion in the antioxidant defence mechanism [32]. This evidence concerns the gene NFE2L2 and diabetic kidney disease.